Coming October 2: SITC releases abstract titles with each presenting author’s institution (nearly 1,300 last year). We’ll add them to this guide once they’re out.

Gustave Roussy at SITC 2026

Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website

Gustave Roussy takes part in 2 sessions at SITC 2026 in Phoenix. Its program centres on new cancer drugs in development and emerging technologies. Its most specific topic is antibody-drug conjugates, including the immune-stimulating versions known as iADCs.

Organization

SITC 2026 Attendance

Gustave Roussy

Villejuif, France

gustaveroussy.fr

Cancer centres & hospitals

Cancer hospital and research center near Paris, affiliated with Paris-Saclay University.

Workshop

Thu Nov 5
8:00am–4:15pm

New Agents in Development and Emerging Technologies

8:00am–9:50amSession I: Cell Therapies and Technologies
10:05am–11:50amSession II: Immune Cell Engagers and Bispecifics
1:30pm–2:55pmSession III: ADC/iADC
3:10pm–4:15pmSession IV: Emerging Technologies – Incorporation into Clinical Trials

Workshop

Thu Nov 5
1:30pm–2:55pm

Session III: ADC/iADC

Valley of the Sun Ballroom

New agents

1:30pm–1:45pmLearning from History: Designing Antibody Drug Conjugates for ImmunotherapyUniversity of Michigan
1:45pm–1:55pmIza-bren: BMS's First Bispecific ADC, and Pumitamig, the PD-L1×VEGF-A Bispecific AntibodyBristol Myers Squibb
1:55pm–2:05pm(TM) ASP2998, a TROP2-targeted ADC with Dual Payloads-Preclinical DataAstellas Pharma
2:05pm–2:15pmTAK-928 (IBI-363): A First-in-class PD-1/IL-2 α-bias Bispecific Fusion ProteinTakeda
2:15pm–2:25pmPD-1 × IL-15 Bispecific Antibodies: Synergistic Immunoactivation in Solid TumorsSanofi
2:25pm–2:35pmIndustry Talk with Clinical DataGenmab

Instantly find 20 buyers from Gustave Roussy

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the Society for Immunotherapy of Cancer (SITC). Submit a correction